BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- DH Yang, M.D, Ph.D
Chonnam National University Hospital
Principal Investigator - DH Yoon, M.D, Ph.D
Asan Medical Center
Principal Investigator - EY Lee, M.D, M.S
National Cancer Center
Principal Investigator - Emily Curran, M.D, Ph.D
University of Cincinnati
Principal Investigator - JO Lee, M.D, Ph.D
Seoul National University Bundang Hospital
Principal Investigator - JS Kim, M.D, Ph.D
Severance Hospital, Yonsei University Health System
Principal Investigator - Jorge Chaves, M.D, Ph.D
Northwest Medical Specialities, PLLC
Principal Investigator - SJ Kim, M.D, Ph.D
Samsung Medical Center
Principal Investigator - TM Kim, M.D, Ph.D
Seoul National University Hospital
Principal Investigator - WS Lee, M.D, Ph.D
Inje University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
- Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
- Chonnam National University Hwasun Hospital
Hwasun, Jeollanam-do, South Korea
- Inje University Busan Paik Hospital
Busan, South Korea
- Asan Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital, Yonsei University Health System
Seoul, South Korea
- Henry Ford Hospital
Detroit, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Apr 2020
- Primary completion
- 21 Sept 2023
- Completion
- 21 Sept 2023
- Last update posted
- 10 Sept 2025
- Registered enrollment
- 26
- Registry id
- NCT04018248
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.